4.7 Article

ABCD1 dysfunction alters white matter microvascular perfusion

期刊

BRAIN
卷 140, 期 -, 页码 3139-3152

出版社

OXFORD UNIV PRESS
DOI: 10.1093/brain/awx262

关键词

cerebral X-linked adrenoleukodystrophy; ALD; ABCD1; inflammatory demyelination; microvascular perfusion

资金

  1. National Institute of Neurological Disorders and Stroke (NINDS) [K12NS066225, K08NS52550]

向作者/读者索取更多资源

Cerebral X-linked adrenoleukodystrophy is a neurodegenerative disorder caused by mutations in ABCD1. By applying a vascular model to conventional MR perfusion imaging, Lauer et al. demonstrate that ABCD1 deficiency causes alterations in microvascular flow in white matter areas and developmental stages with the highest probability for conversion to cerebral disease.Cerebral X-linked adrenoleukodystrophy is a devastating neurodegenerative disorder caused by mutations in the ABCD1 gene, which lead to a rapidly progressive cerebral inflammatory demyelination in up to 60% of affected males. Selective brain endothelial dysfunction and increased permeability of the blood-brain barrier suggest that white matter microvascular dysfunction contributes to the conversion to cerebral disease. Applying a vascular model to conventional dynamic susceptibility contrast magnetic resonance perfusion imaging, we demonstrate that lack of ABCD1 function causes increased capillary flow heterogeneity in asymptomatic hemizygotes predominantly in the white matter regions and developmental stages with the highest probability for conversion to cerebral disease. In subjects with ongoing inflammatory demyelination we observed a sequence of increased capillary flow heterogeneity followed by blood-brain barrier permeability changes in the perilesional white matter, which predicts lesion progression. These white matter microvascular alterations normalize within 1 year after treatment with haematopoietic stem cell transplantation. For the first time in vivo, our studies unveil a model to assess how ABCD1 alters white matter microvascular function and explores its potential as an earlier biomarker for monitoring disease progression and response to treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据